CWG
KERX

C WorldWide Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

C WorldWide Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-26,000
Closed -$152K – 138
2016
Q4 		$152K Sell
26,000
-490,110
-95% -$2.68M ﹤0.01% 120
2016
Q3 		$2.74M Buy
516,110
+95,000
+23% +$512K 0.05% 78
2016
Q2 		$2.79M Hold
421,110
– – 0.05% 63
2016
Q1 		$1.97M Hold
421,110
– – 0.04% 70
2015
Q4 		$2.13M Hold
421,110
– – 0.04% 77
2015
Q3 		$1.48M Buy
421,110
+1,110
+0.3% +$7.43K 0.02% 94
2015
Q2 		$4.19M Sell
420,000
-490,302
-54% -$5.26M 0.06% 64
2015
Q1 		$11.6M Buy
910,302
+104,800
+13% +$1.35M 0.17% 39
2014
Q4 		$11.4M Sell
805,502
-434,304
-35% -$6.73M 0.17% 39
2014
Q3 		$16.8M Buy
+1,239,806
New +$19M 0.25% 33

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

C WorldWide Group's KERX Position: Q1 2017 in Review

C WorldWide Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2017, closing a stake of 26,000 shares — an estimated $152K sold.

C WorldWide Group first reported a position in KERX in Q3 2014 and held it in 10 quarters. The position peaked at $16.8M in Q3 2014. 119 funds tracked by Wall St. Rank hold KERX as of Q1 2017.

  • C WorldWide Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • C WorldWide Group sold 26,000 Keryx Biopharmaceuticals Inc shares in Q1 2017, an estimated $152K.
  • C WorldWide Group first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
  • C WorldWide Group's Keryx Biopharmaceuticals Inc position peaked at $16.8M in Q3 2014.
  • 119 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2017.

Based on C WorldWide Group's 13F filing for Q1 2017, filed 1 May 2017.